Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).

Abstract

Recent approaches for recurrent respiratory papillomatosis including local injection of bevacizumab and HPV vaccination show promise in reducing the need for frequent surgeries. In this study we propose a new combined approach of surgery, intralesional injection of 25mg bevacizumab and HPV vaccine that can lead to resolution of RRP. Our study involved 5 patients treated with a combination of transoral microsurgery, intralesional injection of 25mg bevacizumab, and HPV vaccination with Gardasil 9 between April 2020 and May 2023. Standard video laryngoscopy was performed to assess the presence of papilloma and Derkay score was used to assess the severity of disease. All 5 patients completed the study successfully and a complete response was achieved by all. The follow-up ranged from 8 to 45months. The mean total Derkay score before treatment was 41 (range 25 to 52) and after the combined approach was 0 both anatomically and clinically in all patients. This study demonstrates the effectiveness of a combined treatment approach for RRP involving surgical intervention, intralesional injection of bevacizumab, and HPV vaccination.